KO · Healthcare

Samsung Biologics Co Ltd (207940)

Biotechnology

Samsung Biologics Co Ltd (207940) is listed on KO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 207940

P/E ratio

25.00

Samsung Biologics Co Ltd (207940) — FAQ

What is 207940's P/E ratio?

The price-to-earnings (P/E) ratio for Samsung Biologics Co Ltd (207940) is 25.00 (data as of 2026-05-24).

Does Samsung Biologics Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Samsung Biologics Co Ltd (207940). Check the MyAverix Finance app for the latest dividend data.

What sector is Samsung Biologics Co Ltd in?

Samsung Biologics Co Ltd (207940) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 207940 listed on?

207940 is listed on KO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)